PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 39 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $11,000 | -62.1% | 111,953 | +42.0% | 0.00% | – |
Q2 2016 | $29,000 | -3.3% | 78,818 | 0.0% | 0.00% | – |
Q1 2016 | $30,000 | -6.2% | 78,818 | -3.7% | 0.00% | – |
Q4 2015 | $32,000 | -28.9% | 81,818 | +3.8% | 0.00% | – |
Q3 2015 | $45,000 | -25.0% | 78,818 | -29.5% | 0.00% | -100.0% |
Q2 2015 | $60,000 | -18.9% | 111,818 | +23.7% | 0.00% | 0.0% |
Q1 2015 | $74,000 | +23.3% | 90,400 | +19.9% | 0.00% | 0.0% |
Q4 2014 | $60,000 | +20.0% | 75,400 | +54.2% | 0.00% | 0.0% |
Q3 2014 | $50,000 | +85.2% | 48,900 | +55.7% | 0.00% | – |
Q2 2014 | $27,000 | – | 31,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,226,961 | $824,000 | 0.12% |
HOME FEDERAL BANK OF TENNESSEE | 100,000 | $37,000 | 0.02% |
Cutter & CO Brokerage, Inc. | 84,500 | $31,000 | 0.01% |
PRINCETON CAPITAL MANAGEMENT LLC | 10,000 | $4,000 | 0.01% |
WADE G W & INC | 80,000 | $30,000 | 0.01% |
Estate Counselors, LLC | 10,000 | $4,000 | 0.00% |
SABBY MANAGEMENT, LLC | 93,283 | $35,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 11,466 | $4,000 | 0.00% |
ACADEMY CAPITAL MANAGEMENT INC/TX | 20,000 | $6,000 | 0.00% |
Tower Research Capital LLC (TRC) | 27,451 | $10,000 | 0.00% |